Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Pathology Outlines of Post-COVID-19 Pulmonary Fibrosis Comparative with Idiopathic Pulmonary Fibrosis

Version 1 : Received: 28 April 2023 / Approved: 4 May 2023 / Online: 4 May 2023 (04:09:04 CEST)

A peer-reviewed article of this Preprint also exists.

Cîrjaliu, R.-E.; Deacu, M.; Gherghișan, I.; Marghescu, A.-Ș.; Enciu, M.; Băltățescu, G.I.; Nicolau, A.A.; Tofolean, D.-E.; Arghir, O.C.; Fildan, A.-P. Clinicopathological Outlines of Post-COVID-19 Pulmonary Fibrosis Compared with Idiopathic Pulmonary Fibrosis. Biomedicines 2023, 11, 1739. Cîrjaliu, R.-E.; Deacu, M.; Gherghișan, I.; Marghescu, A.-Ș.; Enciu, M.; Băltățescu, G.I.; Nicolau, A.A.; Tofolean, D.-E.; Arghir, O.C.; Fildan, A.-P. Clinicopathological Outlines of Post-COVID-19 Pulmonary Fibrosis Compared with Idiopathic Pulmonary Fibrosis. Biomedicines 2023, 11, 1739.

Abstract

This review brings together the current knowledge regarding the risk factors, and the clinical, radiologic and histological features of both post-COVID-19 interstitial pul-monary fibrosis (PCPF) and Idiopathic Pulmonary Fibrosis (IPF) with a particular fo-cus on describing the similarities and the disparities between the fibrotic changes in these two diseases. It is important to highlight the common points of PCPF and IPF to observe if they are some targetable changes to improve patient outcomes. The litera-ture review was performed using numerous databases to identify relevant articles published in English through October 2022. This review would help clinicians, pathologists and researchers to make an accurate diagnosis, which can be useful in identifying the group of patients who can be selected for antifibrotic therapies, and future therapeutic perspectives.

Keywords

Covid-19; idiopathic pulmonary fibrosis; interstitial lung disease; pulmonary fibrosis

Subject

Medicine and Pharmacology, Pulmonary and Respiratory Medicine

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.